newsfilter
← Latest News
PR Newswire·

MYND Life Sciences Announces Diagnostic Division with Formation of Wholly-Owned Subsidiary - MYND Diagnostics Ltd.

MYND Diagnostics was formed to commercialize proprietary biomarker diagnostic tests for patients suffering from MDD, TRD and other psychiatric disorders. VANCOUVER, BC, Oct. 7, 2021 /PRNewswire/ - MYND Life Sciences Inc. (CSE:MYND) (OTC:MYNDF) ("M